Article Details
Retrieved on: 2024-07-26 16:06:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... alopecia areata, a common autoimmune disease. The approval is based on the data from Phase 3 clinical trials THRIVE-AA1 and THRIVE-AA2, which ...
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here